Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01219647 · ClinicalTrials.gov registry record · Phase 1

Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis

A Phase 1 study of Multiple Sclerosis, sponsored by University of California, Los Angeles.

Completed
Registry status
Phase 1
Development phase
35
Enrollment target
2
Study locations

NCT01219647: Completed Phase 1 study of Multiple Sclerosis, sponsored by University of California, Los Angeles.

NCT01219647 is a Phase 1 study of Multiple Sclerosis that has completed, run by University of California, Los Angeles. The registered enrollment target is 35 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01219647, a Phase 1 study of Multiple Sclerosis, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
Phase 1
Development phase
35 participants
Enrollment target
2
Study locations

Study Summary

Many persons with Multiple Sclerosis ( MS) have problems with memory and thinking.Exercise has been shown to improve memory and thinking in persons with diseases such as Alzheimer's. This study will investigate whether a program of aerobic exercise can improve memory and thinking in persons with MS

Primary Outcome

test of attention and information processing

Conditions Studied

Multiple Sclerosis

Interventions

  • BEHAVIORAL stretching
  • BEHAVIORAL exercise

Study Locations (2)

California

  • UCalifornia at Los Angeles - Los Angeles
  • CAl State University at Northridge - Northridge

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2010-07
Est. Completion 2014-08
Phase Phase 1
University of California, Los Angeles

897 total trials

What the finished NCT01219647 record still lists

NCT01219647 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which stretching is the first listed.

NCT01219647 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01219647 about?

NCT01219647 is a clinical study titled "Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis". Many persons with Multiple Sclerosis ( MS) have problems with memory and thinking.Exercise has been shown to improve memory and thinking in persons with diseases such as Alzheimer's. This study will investigate whether a program of aerobic exercise can improve memory and thinking in persons with MS

What is the current status of trial NCT01219647?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2010-07. Estimated completion is 2014-08.

What conditions does trial NCT01219647 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT01219647?

The interventions under investigation include: stretching (BEHAVIORAL), exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01219647?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01219647 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01219647's enrollment target sits among peer trials

35 214th of 315 higher than 101 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01697371 · 35 participants · NA

    Proton Therapy in the Treatment of Liver Metastases

  • NCT01940757 · 35 participants · Phase 1

    Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae

  • NCT02235857 · 35 participants · NA

    Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

  • NCT02637934 · 35 participants · Phase 1

    Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01219647, the US trial registry maintained by the National Library of Medicine. NCT01219647 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.